Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(702)
Kurt Possinger
64
Ulrike Heider
48
Christian Jakob
47
Jan Eucker
30
Ivana Zavrski
30
Journals
(46)
EUR J CANCER
31
EUR J HAEMATOL
19
Leukemia
15
ANN HEMATOL
8
ANTI-CANCER DRUG
7
Keywords
(356)
Embed
Subscribe
Academic
Authors
Orhan Sezer
Orhan Sezer,University of Hamburg,Oncology,Pharmacology,Cell Biology
Edit
Orhan Sezer
University of Hamburg
Publications:
173
|
Citations:
2670
Fields:
Oncology
,
Pharmacology
,
Cell Biology
View FAQ about top research areas and Fields of study
Collaborated with
702 co-authors
from 1997 to 2012
|
Cited by
8434 authors
Cumulative
Annual
Sort by:
Publications
(173)
BibTeX
|
RIS
|
RefWorks
Download
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
S K Kumar
,
J H Lee
,
J J Lahuerta
,
G Morgan
,
P G Richardson
,
J Crowley
,
J Haessler
,
J Feather
,
A Hoering
,
P Moreau
,
X LeLeu
,
C Hulin
O Sezer
http://academic.research.microsoft.com/io.ashx?type=5&id=56564055&selfId1=23586895&selfId2=0&maxNumber=12&query=
Journal:
Leukemia
, vol. 26, no. 1, pp. 149-157, 2012
Management of treatment-emergent peripheral neuropathy in multiple myeloma
P G Richardson
,
M Delforge
,
M Beksac
,
P Wen
,
J L Jongen
,
O Sezer
,
E Terpos
,
N Munshi
,
A Palumbo
,
S V Rajkumar
,
J L Harousseau
,
P Moreau
http://academic.research.microsoft.com/io.ashx?type=5&id=56564173&selfId1=23586895&selfId2=0&maxNumber=12&query=
Journal:
Leukemia
, vol. 26, no. 4, pp. 595-608, 2012
International myeloma working group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation
M. Cavo
,
S. V. Rajkumar
,
A. Palumbo
,
P. Moreau
,
R. Z. Orlowski
,
J. Bladé
,
O. Sezer
,
H. Ludwig
,
M. A. Dimopoulos
,
M. Attal
,
P. Sonneveld
,
M. Boccadoro
http://academic.research.microsoft.com/io.ashx?type=5&id=59496187&selfId1=23586895&selfId2=0&maxNumber=12&query=
Journal:
Blood
, vol. 117, no. 23, pp. 6063-6073, 2011
Consensus recommendations for risk stratification in multiple myeloma: Report of the International Myeloma Workshop Consensus Panel 2
N. C. Munshi
,
K. C. Anderson
,
P. L. Bergsagel
,
J. Shaughnessy
,
A. Palumbo
,
B. G. M. Durie
,
R. Fonseca
,
A. K. Stewart
,
J. L. Harousseau
,
M. A. Dimopoulos
,
S. Jagannath
,
R. Hajek
O. Sezer
http://academic.research.microsoft.com/io.ashx?type=5&id=59496179&selfId1=23586895&selfId2=0&maxNumber=12&query=
Journal:
Blood
, vol. 117, no. 18, pp. 4696-4700, 2011
Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches
(
Citations: 5
)
Monika Engelhardt
,
Martina Kleber
,
Josefina Udi
,
Ralph Wäsch
,
Andrew Spencer
,
Francesca Patriarca
,
StefAn Knop
,
Benedetto Bruno
,
Martin Gramatzki
,
Fortunato Morabito
,
Martin Kropff
,
Antonino Neri
Orhan Sezer
http://academic.research.microsoft.com/io.ashx?type=5&id=33297340&selfId1=23586895&selfId2=0&maxNumber=12&query=
Journal:
Leukemia & Lymphoma - LEUK LYMPHOMA
, vol. 51, no. 8, pp. 1424-1443, 2010
Sort by:
Citations
(2670 times by 1984 publications)
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
S K Kumar
,
J H Lee
,
J J Lahuerta
,
G Morgan
,
P G Richardson
,
J Crowley
,
J Haessler
,
J Feather
,
A Hoering
,
P Moreau
,
X LeLeu
,
C Hulin
O Sezer
http://academic.research.microsoft.com/io.ashx?type=5&id=56564055&selfId1=23586895&selfId2=0&maxNumber=12&query=
Journal:
Leukemia
, vol. 26, no. 1, pp. 149-157, 2012
Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria
(
Citations: 1
)
G Finazzi
,
A Carobbio
,
J Thiele
,
F Passamonti
,
E Rumi
,
M Ruggeri
,
F Rodeghiero
,
M L Randi
,
I Bertozzi
,
A M Vannucchi
,
E Antonioli
,
H Gisslinger
http://academic.research.microsoft.com/io.ashx?type=5&id=56564124&selfId1=23586895&selfId2=0&maxNumber=12&query=
Journal:
Leukemia
, vol. 26, no. 4, pp. 716-719, 2012
Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA
K W Douglas
,
A N Parker
,
P J Hayden
,
A Rahemtulla
,
A D'Addio
,
R M Lemoli
,
K Rao
,
M Maris
,
A Pagliuca
,
J Uberti
,
C Scheid
,
R Noppeney
http://academic.research.microsoft.com/io.ashx?type=5&id=56543933&selfId1=23586895&selfId2=0&maxNumber=12&query=
Journal:
Bone Marrow Transplantation - BONE MARROW TRANSPLANT
, vol. 47, no. 1, pp. 18-23, 2012
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial
K D Boyd
,
F M Ross
,
L Chiecchio
,
G P Dagrada
,
Z J Konn
,
W J Tapper
,
B A Walker
,
C P Wardell
,
W M Gregory
,
A J Szubert
,
S E Bell
,
J A Child
http://academic.research.microsoft.com/io.ashx?type=5&id=56564065&selfId1=23586895&selfId2=0&maxNumber=12&query=
Journal:
Leukemia
, vol. 26, no. 2, pp. 349-355, 2012
The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries
J Abelsson
,
M Merup
,
G Birgegård
,
O WeisBjerrum
,
L Brinch
,
M Brune
,
P Johansson
,
M Kauppila
,
S Lenhoff
,
M Liljeholm
,
C Malm
,
K Remes
http://academic.research.microsoft.com/io.ashx?type=5&id=56543924&selfId1=23586895&selfId2=0&maxNumber=12&query=
Journal:
Bone Marrow Transplantation - BONE MARROW TRANSPLANT
, vol. 47, no. 3, pp. 380-386, 2012
Comments